Cyclo Therapeutics closes enrolment in Phase I NPC trial
NPC is a rare, genetic disease that affects every cell in the body. Credit: Mark Warner.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more